HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC labeling rule

This article was originally published in The Rose Sheet

Executive Summary

FDA "feedback" meeting with the Cosmetic, Toiletry and Fragrance Association and Consumer Healthcare Products Association is scheduled for June 29 at 10 a.m. The meeting will be held at 5600 Fishers Lane, Conference Room D in Rockville, Md. CHPA said it wanted to hold discussions with the agency on the final rule before conducting a member survey evaluating the effect of the new regulation ("The Rose Sheet" June 7, p. 4). Discussion is expected to address the use of dual-columns as requested by CHPA; in a May 27 letter, OTC Office then-Acting Director Debra Bowen, MD, said the agency would be "willing to consider" the alternative format

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006822

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel